This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Dipharma S.p.a., Dipharma Francis S.r.l.. Active years: 2008-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2012
Title: The Innovative Journey of Tiziano Scubla
Introduction: Tiziano Scubla, an accomplished inventor based in Pasian di Prato, Italy, has made significant contributions to the field of chemistry with his innovative research. With a total of five patents to his name, Scubla has demonstrated a strong commitment to advancing scientific knowledge and practical applications in his area of expertise.
Latest Patents: Among his most recent inventions are two notable patents. The first is a "Process for the preparation of keto compounds," specifically detailing the production of 4-[1-oxo-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethylbenzeneacetic acid. This compound proves to be a crucial intermediate in the synthesis of fexofenadine, an antihistamine medication. The second patent focuses on a "Process for the preparation of cholanic acids," which describes a method to obtain high purity cholanic acids, achieving high purities of 99% or more.
Career Highlights: Tiziano Scubla has garnered experience working with reputable companies such as Dipharma S.p.a. and Dipharma Francis S.r.l. His work in these organizations has not only honed his skills as an inventor but also solidified his reputation in the pharmaceutical and chemical industries.
Collaborations: Throughout his career, Scubla has had the opportunity to collaborate with esteemed colleagues, including Fausto Gorassini and Nevio Francescutti. These collaborations have allowed for the exchange of ideas and the acceleration of innovative projects in their field.
Conclusion: Tiziano Scubla continues to inspire with his inventions and advancements in chemical processes. His patents reflect a dedication to improving pharmaceutical applications and contribute to the ongoing development of effective therapeutic agents. As he pushes the boundaries of innovation, he remains a prominent figure in the landscape of modern inventors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
